BERG, Sanofi Pasteur Team Up to Assess Potential Biomarkers of Seasonal Influenza Vaccination Outcomes

BERG is working with Sanofi Pasteur, the influenza vaccine global leader, to generate and model data using BERG’s Interrogative Biology® platform to assess potential biomarkers of seasonal influenza vaccination outcomes in an unbiased and data-driven manner.